#1 Clinical Trials Search in Europe

Irbesartan

Irbesartan is a medication used to treat high blood pressure, also known as hypertension. This article explores various clinical trials that have investigated the use of Irbesartan, both alone and in combination with other drugs, to manage hypertension and protect kidney function in patients with diabetes. These studies aim to determine the most effective dosages, compare Irbesartan with other treatments, and evaluate its safety profile in different patient populations.

Table of Contents

What is Irbesartan?

Irbesartan is a medication primarily used to treat high blood pressure, also known as hypertension. It belongs to a class of drugs called angiotensin receptor blockers (ARBs)[1]. Irbesartan is sometimes referred to by its brand name Aprovel[2] or Avapro[3]. This medication is available in tablet form and is typically taken orally once daily[4].

Medical Conditions Treated

Irbesartan is primarily used to treat the following conditions:

  • Hypertension (High Blood Pressure): This is the main condition for which Irbesartan is prescribed. It helps lower blood pressure in patients with mild to moderate essential hypertension[5].
  • Diabetic Nephropathy: Irbesartan is also used to treat kidney problems in patients with type 2 diabetes and high blood pressure. It can help slow down kidney damage in these patients[6].
  • Protection after Acute Kidney Injury: Some studies are investigating the use of Irbesartan in patients who have experienced acute kidney injury, to potentially improve long-term outcomes[1].

How Irbesartan Works

Irbesartan works by blocking the action of a hormone called angiotensin II. This hormone causes blood vessels to narrow, which can increase blood pressure. By blocking this hormone, Irbesartan allows blood vessels to relax and widen, leading to a decrease in blood pressure[1].

In patients with diabetes and kidney problems, Irbesartan helps protect the kidneys by reducing the strain on blood vessels in the kidneys. This can slow down the progression of kidney damage[6].

Dosage and Administration

Irbesartan is typically taken orally once daily. The dosage can vary depending on the patient’s condition and response to treatment:

  • For hypertension, the usual starting dose is 150 mg once daily. This can be increased to 300 mg if needed[5].
  • For diabetic nephropathy, a higher dose of 300 mg once daily is often used[6].
  • In some cases, Irbesartan may be combined with other blood pressure medications, such as amlodipine, for better control of hypertension[4].

It’s important to take Irbesartan exactly as prescribed by your doctor. Do not change your dose or stop taking the medication without consulting your healthcare provider.

Efficacy and Benefits

Clinical studies have shown that Irbesartan is effective in:

  • Lowering both systolic (the top number) and diastolic (the bottom number) blood pressure[4].
  • Reducing the risk of kidney damage progression in patients with type 2 diabetes and high blood pressure[6].
  • Potentially improving endothelial function, which is the health of the inner lining of blood vessels[7].

Some studies suggest that Irbesartan may have additional benefits, such as reducing oxidative stress (a type of cellular damage) in patients with metabolic syndrome, but more research is needed to confirm these effects[7].

Side Effects and Safety

Like all medications, Irbesartan can cause side effects, although not everyone experiences them. Common side effects may include:

  • Dizziness
  • Fatigue
  • Nausea
  • Elevated potassium levels in the blood (hyperkalemia)[1]

In rare cases, more serious side effects can occur. These may include severe allergic reactions, kidney problems, or low blood pressure. It’s important to contact your doctor immediately if you experience any unusual or severe side effects.

Special Considerations

There are several important factors to consider when taking Irbesartan:

  • Pregnancy: Irbesartan can cause harm to an unborn baby and should not be used during pregnancy[1].
  • Kidney function: Your doctor may need to monitor your kidney function while you’re taking Irbesartan, especially if you have pre-existing kidney problems[6].
  • Other medications: Irbesartan can interact with other drugs, including some over-the-counter medications. Always inform your doctor about all medications you’re taking[4].
  • Diet: Some studies have looked at how food affects the absorption of Irbesartan. While it can be taken with or without food, it’s best to be consistent in how you take it[8].

Remember, Irbesartan is a prescription medication and should only be taken under the guidance of a healthcare professional. Regular check-ups and blood pressure monitoring are important to ensure the medication is working effectively and safely for you.

Aspect Details
Primary Uses Treatment of hypertension, potential kidney protection in diabetic patients
Dosages Studied 150mg and 300mg daily
Combination Therapies Irbesartan with Amlodipine, Irbesartan with Hydrochlorothiazide
Key Outcomes Measured Changes in blood pressure, urinary albumin excretion rate, forearm vascular resistance
Study Durations Ranging from 8 to 12 weeks or longer
Patient Populations Hypertensive patients, diabetics with microalbuminuria, patients with essential hypertension
Safety Assessments Incidence and severity of adverse events, tolerability comparisons

FAQ

  • What is Irbesartan used for? Irbesartan is primarily used to treat high blood pressure (hypertension). Some clinical trials have also explored its potential in protecting kidney function in patients with diabetes and microalbuminuria (a sign of early kidney damage).
  • How does Irbesartan compare to other blood pressure medications? Clinical trials have compared Irbesartan to other blood pressure medications and combinations. For example, some studies have looked at the efficacy of Irbesartan combined with Amlodipine compared to Irbesartan alone in patients whose blood pressure was not well-controlled on Irbesartan monotherapy.
  • What dosages of Irbesartan have been studied in clinical trials? Various dosages have been studied, including 150mg and 300mg daily. Some trials have compared the effectiveness of different dosages, such as 150mg vs. 300mg, in managing blood pressure and protecting kidney function.
  • Are there any side effects associated with Irbesartan in clinical trials? While specific side effects are not detailed in the provided trial summaries, many studies included safety assessments. For example, one study aimed to determine the incidence and severity of adverse events. It's important to note that all medications can have potential side effects, and these are typically monitored closely in clinical trials.
  • How long do clinical trials for Irbesartan typically last? The duration of Irbesartan clinical trials varies. Some studies lasted for 8 weeks, while others extended up to 12 weeks or longer. The length of the trial often depends on the specific outcomes being measured and the study design.

Ongoing Clinical Trials on Irbesartan

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study on Patiromer for Improving RAAS Treatment in Patients with Chronic Kidney Disease Stages 3b/4

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study Comparing Eplerenone and Irbesartan for Lowering Blood Pressure in Obese Patients with Hypertension

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece

  • Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia Czechia Estonia France Germany +5

  • Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Croatia Czechia Denmark Estonia France +6

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Greece

  • Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Italy Portugal +1

  • Study on the Effects of Irbesartan After Acute Kidney Injury in Patients Discharged from ICU

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Hypertension: A medical condition in which the blood pressure in the arteries is persistently elevated. It's often referred to as high blood pressure.
  • Microalbuminuria: The presence of small amounts of a protein called albumin in the urine, which can be an early sign of kidney damage, especially in people with diabetes.
  • Systolic Blood Pressure (SBP): The pressure in the arteries when the heart beats, pumping blood into the arteries. It's the higher number in a blood pressure reading.
  • Diastolic Blood Pressure (DBP): The pressure in the arteries when the heart is at rest between beats. It's the lower number in a blood pressure reading.
  • Monotherapy: Treatment of a condition with a single drug.
  • Bioequivalence: A term in pharmacology used to assess the expected in vivo biological equivalence of two different preparations of a drug. If two products are bioequivalent, they should have the same efficacy and safety.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Randomized Clinical Trial: A type of scientific experiment designed to reduce bias when testing a new treatment. The participants are randomly allocated to receive either the treatment under investigation or a placebo/standard treatment.
  • Placebo-controlled: A method of investigation in which an inactive substance (placebo) is given to one group of participants, while the drug being tested is given to another group. The results are compared to see if the drug is more effective than the placebo.

References

  1. https://clinicaltrials.eu/trial/study-on-the-effects-of-irbesartan-after-acute-kidney-injury-in-patients-discharged-from-icu/
  2. https://clinicaltrials.gov/study/NCT00564187
  3. https://clinicaltrials.gov/study/NCT01712113
  4. https://clinicaltrials.gov/study/NCT00950066
  5. https://clinicaltrials.gov/study/NCT00562809
  6. https://clinicaltrials.gov/study/NCT00334581
  7. https://clinicaltrials.gov/study/NCT00529750
  8. https://clinicaltrials.gov/study/NCT01712100